Biopharma

Accelerate the Next Wave of Therapeutics

Caris is revolutionizing precision oncology through integration of comprehensive molecular profiling with massive, multimodal datasets to unravel the complexities of cancer.

Caris Biopharma is designed to empower partners at every stage of the development cycle. With answers that enable more informed program decisions, biopharma partners can increase efficiencies, reduce costs and mitigate risk. These advantages accelerate the development of new therapies and help improve patient lives.

Core Services

Multimodal Data

Caris Discovery

INSIGHTS

Access Deeper Insights for Every Phase of Development

With a multimodal data set that combines deep molecular insights from hundreds of thousands of patients with real-world clinical outcomes, Caris Biopharma Solutions can help inform, empower and optimize every phase of your development.

Inform with insights from the industry’s most comprehensive clinico-genomic database.

Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS)
Immunohistochemistry (IHC)
Matched real-world claims and electronic health record data
Unstained FFPE (Formalin Fixed Paraffin Embedded) tissue slides, whole slide IHC imaging, and clinico-molecular data to develop and validate any DNA or RNA biomarker across 23K genes

Empower through Precision Partnering with customizable offerings.

Answers from either tissue or blood samples
One platform for clinical trials
State-of-the-art equipment and facilities
Global regulatory and commercial capabilities

Optimize outcomes based on real-world insights.

Uniformity and consistency in profiling makes for streamlined analysis and reduction of bias in datasets.
Robust Datasets allow for project scalability, stratification, and ideal patient populations
Access to multidisciplinary team of more than 735 clinicians, scientists, researchers, and technologists
Deep experience to support and help accelerate programs from discovery to commercialization as quickly as possible

Integrated Commercial Team

Support from ordering to results interpretation

Sales Force Targeting

Enable rapid sales force deployment via biomarker-based alerts for commercial success

Multimodal Data Licensing

Access to Caris databases through collaborative engagements or data licensing models

Companion Diagnostics

Optimize approaches for developing, validating & launching novel CDx biomarkers

Target ID & Validation

Wet lab and in silico target ID & validation

Molecular Profiling (Solid & Liquid)

Comprehensive WES/WTS and select IHC to accelerate development programs with data-driven decisions

Trial Matching

Accelerate enrollment by identifying biomarker+ patients from Caris commercial cases

Digital Pathology

Biomarker specific algorithms to
support validation and diagnostics

Real-World Data Analytics

Utilizing multimodal database to better understand outcomes

Solutions

Leverage a Full Suite of Caris Solutions

Gain confidence with data driven decisions

Building upon MI Cancer Seek, the US market leader in comprehensive genomic tissue profiling, Caris not only connects patients with therapies and clinical trials, but also connects drug developers with an experienced profiling laboratory infrastructure to support discovery, clinical development, translational medicine and commercialization.